Koninklijke Philips NV (PHG) News & EventsPHGKoninklijke Philips NV

Raises FY26 Adjusted EBITA Margin View to 13.5%-14%

Raises FY26 adjusted EBITA margin view 13.5%-14% from 12.5%-13.0% previously. Raises FY26 free cash flow view to EUR1.5B-EUR.17B from EUR1.3B-EUR1.5B previously. The new guidance is updated to reflect the U.S. tariff refund benefit.

Philips Reports Q2 Revenue of €4.36B

Reports Q2 revenue EUR4.36B vs EUR4.338B last year. Comparable sales increased by 4%, driven by growth across all segments. Diagnosis & Treatment comparable sales increased by 2%, Connected Care by 2%, and Personal Health by 8%. Adjusted EBITA margin increased to 16.4%, including US tariff refund benefit of effectively 4.2%. "We delivered another solid quarter with comparable sales growth of 4%, driven by all business segments, and strong disciplined execution within an uncertain macro environment. Customer demand for our innovations remains healthy, with certain large orders in North America shifting into the third quarter, while Europe delivered strong double-digit order growth," said CEO Roy Jakobs. "Our plan continues to gain traction, creating value through focused segment strategies, differentiated platform innovations, commercial excellence and disciplined execution. We launched SmartIQ for our Azurion image-guided therapy platform and received several new regulatory clearances for our AI-powered innovations. Our teams around the world are focused on delivering better care for more people. We largely completed the US tariff refund process during the quarter and continue to actively manage the broader macro environment, including inflation. Our productivity program is on track, helping to largely offset these pressures. We are strengthening our supply chain resilience as we continue to put quality at the heart of our operations."